About us

Bioseutica is a world-leading ingredient company whose natural proteins and enzymes are innovative and selected as the first choice for food, feed and pharma sectors. Bioseutica aims to become a world market leader catalyzing responsible development of natural high-quality proteins and enzymes.

Bioseutica is committed to scientific research leading to innovative products and proprietary technologies. Bioseutica focuses on the global supply of the highest quality bioactive proteins, including egg derived proteins, lysozyme, avidin, ovomucoid, ovalbumin  and ovotransferrin, pancreatic enzymes and specialty products, food ingredients and feed additives, designed for antibiotic-free livestock, such as aqua, poultry and swine, and pets. Bioseutica’s manufacturing processes are built on high-end, cutting-edge proprietary technology and allow us to produce ingredients of highest purities in our manufacturing facilities in Canada and Europe.

Bioseutica's diversified range of products, which include egg-derived proteins, pancreatic enzymes, and specialty end products for the food & feed industry are sold to companies worldwide. In addition, Bioseutica focuses on licensing-related intellectual property. Bioseutica’s organization enables it to efficiently deliver quality products, custom-designed solutions and timely customer service to clients globally. Today, Bioseutica is the global leader in lysozyme1.

Bioseutica's international management team strives to be on top of current consumer demands and industrial market trends worldwide.

Bioseutica's group of scientists and researchers are continuously developing innovative products for our food, feed, and pharmaceutical, customers around the world with a special focus on delivering the highest quality products derived from nature’s sources. Bioseutica applies its know-how and proprietary technology to transform natural commodities into highly concentrated and active ingredients for industrial use. Due to its manufacturing expertise, Bioseutica produces ingredients with high purities targeted to the high-quality segments in the respective markets.

Main business divisions:

  • Health
  • Nutrition
  • Research

Product lines:

  • Lysozyme (Muramidase)
  • Feed Additives
  • Egg Proteins
  • Proteases
  • Lipases
  • Specialties    

Global Footprint

Note:

1. The origins of Bioseutica extend back to 1947 with the birth of PROSPA Pharmaceutical Companies, Solar Group, and SPA, (Società Prodotti Antibiotici), which formed the foundation of what is today Bioseutica. In 2007 the shareholders of Bioseutica acquired Neova Technologies Inc. and its plants in Europe and Canada, a company specializing in the development and production of natural proteins and pancreatic enzymes.

  LYSOZYME
Liquid
LYSOZYME
Granulated
LYSOZYME
Powder API
PROTEASE LIPASE EGG PROTEINS SPECIALTIES
Food              
Pharma              
Feed              
Cosmetics              
Diagnostics              
Cell Biology              
Industrial              
Molecular Biology              
Veterinary              
Nootropics              

Group Companies

Neova Technologies Inc. draws on almost thirty years of expertise in bioseparation and protein fractionation, building its international reputation on quality and service.

Neova takes an integrated approach to product development and quality enhancement. With a strong history in research and development to support the products we sell, our approach is to seek practical solutions that regularly challenge current limits and assumptions.

Neova’s strong team of researchers understands the functionality that our products can bring to the different industries and applications that our customers represent. Some research projects are undertaken with the objective of publication for the benefit of industry, while others are carried out for the benefit of a single customer. Regardless, the same systematic approach to the research applies. In addition, our customers are critical in establishing market needs and identifying opportunities. We take a collaborative approach and work with our customers to identify new products and applications.

Fordras, a Swiss company, has been serving the pharmaceutical and food industries since 1983. Fordras’ international experience in the sales of active pharmaceutical ingredients and food additives makes it one of the leading companies in the development, manufacturing and marketing of specialty, organic products such as Lysozyme. 

At Fordras, our mission is to develop, manufacture and sell natural products aimed at improving people’s health and at enhancing the way foods are processed and preserved. 

The company’s headquarters are located in Lugano, Switzerland. In 2012 Fordras has been integrated to the Bioseutica group. Bioseutica has manufacturing plants located in Denmark, Germany, Holland and Venezuela.